A Randomized, Double-blind, Multi-center, Multi-factorial, Phase 2 Trial to Evaluate the Efficacy and Safety of S-Amlodipine/Telmisartan Combined or Alone and Select Better Dose of CKD-828 in Patients With Essential Hypertension.

Trial Profile

A Randomized, Double-blind, Multi-center, Multi-factorial, Phase 2 Trial to Evaluate the Efficacy and Safety of S-Amlodipine/Telmisartan Combined or Alone and Select Better Dose of CKD-828 in Patients With Essential Hypertension.

Completed
Phase of Trial: Phase II

Latest Information Update: 25 Apr 2011

At a glance

  • Drugs Levamlodipine; Levamlodipine/telmisartan; Telmisartan
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Apr 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 17 Nov 2010 Actual initiation date (Jul 2010) added as reported by ClinicalTrials.gov.
    • 17 Nov 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top